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Abstract 
The mitochondrial permeability transition pore (MPTP) is a non-specific channel in 
the inner mitochondrial membrane (IMM) that opens following ischaemia and 
reperfusion due to the presence of various stimuli, such as oxidative stress, elevated 
phosphate concentration, and adenine nucleotide depletion. MPTP opening causes 
the mitochondria to swell and become dysfunctional. This results in cell death, 
especially by necrosis, due to the loss of oxidative phosphorylation and the 
subsequent drop in adenosine triphosphate levels. In search of the identity of the 
pore numerous studies have been done by several research groups in the last three 
decades. For many years a widely accepted hypothesis prevailed suggesting the 
involvement of the adenine nucleotide translocase (ANT) and voltage-dependent 
anion channel (VDAC) as core proteins of the MPTP. Recent genetic studies, 
however, contradict this hypothesis and ascribe only a regulatory role to the ANT. 
Furthermore, there is now sufficient evidence to conclude that VDAC plays no role in 
mitochondrial permeability transition. In a recent study it was suggested that the 
mitochondrial phosphate carrier (PiC) may fulfil a role as a pore component. 
According to a proposed model MPTP is formed as a consequence of a 
conformational change in the PiC, triggered by calcium binding. Opening of the pore 
may be enhanced through interactions with the ANT in the “c” conformation and 
cyclophilin-D, a mitochondrial matrix protein.       
 
Introduction 
Research in mitochondrial permeability transition (MPT) stems from the observation 
that mitoplasts, mitochondria stripped of their outer membrane, swell and become 
dysfunctional unless placed in a Ca2+ ion-free suspension (Hunter et al. 1976).                                  
Since the mitochondrial inner membrane is impermeable to solutes without specific 
transport mechanisms, the phenomenon has sparked much interest in mitochondrial 
research (Bernardi 1999). Reports in the field agree that MPT is mediated by a 
proteinaceous pore, known as the mitochondrial permeability transition pore (MPTP) 
(Bernardi 1999; Juhaszova et al. 2008). According to Hunter and Haworth (1979) 
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mitochondria undergoing MPT admit molecules of all sizes with a molecular weight 
up to 1.5 kDa. MPTP-associated matrix swelling is driven by the osmotic gradient 
established by the presence of indiffusible matrix proteins (Halestrap et al. 2003). A 
prerequisite to this swelling is that Ca2+ is accumulated in the mitochondrial matrix by 
the Ca2+ uniporter, or channel, located in the inner mitochondrial membrane (Zoratti 
& Szabó 1995). The evidence for the Ca2+-dependent swelling came from a study in 
which Ruthenium Red (RR), an inhibitor of the mitochondrial Ca2+ uniporter was 
used. Blocking calcium entry into the matrix prevented MPT (Hunter & Haworth 
1979). The extent of Ca2+ accumulation, or Ca2+ load in the matrix compartment 
required for MPT was found to be organ specific (e.g. mitochondria from liver were 
more susceptible to permeabilization than heart mitochondria). The rate of MPT and 
the percentage of mitochondria undergoing MPT were also found to be dependent 
on the extent of Ca2+ load (Zoratti & Szabó 1995). They concluded that the 
heterogeneity of mitochondria with respect to their susceptibility to permeabilization 
can be explained by the variation in the presence of different MPT modulators. 
Indeed, it has been found that Ca2+ load alone is often insufficient to induce MPTP 
opening. Additional factors required may be the presence of reactive oxygen species 
(ROS), elevated phosphate concentration, mitochondrial depolarization, and adenine 
nucleotide depletion (Crompton et al 1999). These factors correspond to conditions 
in the heart brought about by ischemia/reperfusion injury that results in tissue 
damage initiated by inadequate oxygen and nutrient supply (Halestrap 2006). It has 
been well documented that the necrotic cell death characteristic of 
ischemia/reperfusion injury is caused by MPTP opening (Crompton 1999). 
Nevertheless, MPTP-associated swelling of the mitochondria can also induce 
apoptosis under some conditions (Kim et al. 2003). It is clear that the MPTP plays an 
important role in cell death and understanding the molecular mechanisms of MPTP 
opening may lead to the development of drugs that target the components of the 
MPTP. The remainder of this review will summarise the evidence for the MPTP 
forming components proposed so far.   
The pore hypothesis 
The hypothesis that MPT is mediated through a proteinaceous pore did not receive 
much attention for a long time. The alternative, prevailing hypothesis was that MPT 
is due to alterations of the phospholipid bilayer (Zoratti & Szabó 1995). According to 
this hypothesis MPT is brought about by the accumulation of lysophospholipids, 
which results in membrane damage. In association with this process the involvement 
of the enzyme phospholipase A2 (PA2) and lysophospholipid-acyl-CoA-transferase 
was suggested (Gunter & Pfeiffer 1990). PA2 catalyses the hydrolysis of the sn-2 
acyl bond of membrane phospholipids releasing arachidonic acid and 
lysophospholipids, which are reincorporated by the opposing activity of 
acyltransferases (Zoratti & Szabó 1995). It was proposed by Gunter and Pfeiffer 
(1990) that the over-activity of PA2 and the inhibition of acyltransferases might 
induce MPT. Although experimental observations confirmed that lysophospholipids 
accumulate in association with MPT, the model failed to account for the “all-or-
nothing” nature of the MPT (Zoratti & Szabó 1995). The evidence in support of the 
pore hypothesis came from the discovery by Crompton et al. (1988) that Cyclosporin 
A (CsA), an immunosupressive drug, could inhibit MPT but it had no effect on PA2 
activity. Work in the same laboratory also identified the target protein on which CsA 
exerts its affect. That protein, now known as cyclophilin D (Cyp-D), was shown to be 
located in the mitochondrial matrix.              
The Plymouth Student Scientist, 2010, 3, (1), 245-254 
 
[247] 
 
Pore components 
Cyclophilin D 
Due to its location and the CsA-sensitive affect on MPT the involvement of Cyp-D as 
a likely candidate in pore formation is evident. Nevertheless, several lines of 
research have pointed out that Cyp-D has a secondary role in pore formation (Clarke 
et al. 2002; Nakagawa et al. 2005; Connern & Halestrap 1996). Cyp-D is a nuclear 
encoded protein that is targeted to the mitochondrial matrix by its mitochondrial 
signal sequence. It belongs to a family of peptidyl prolyl cis/trans isomerases 
(PPIase) that are ubiquitous enzymes involved in promoting protein folding 
(Woodfield et al. 1998). Indeed, the evidence for its role in MPTP formation came 
from the observation that blocking its PPIase activity with CsA correlated with MPT 
inhibition (Griffiths & Halestrap 1991). Studies on mitochondria from Cyp-D knockout 
mice, however, demonstrated that MPTP opening can occur without the involvement 
of Cyp-D at sufficiently high matrix calcium concentration (Baines et al. 2005). In a 
parallel study by Nagawa et al. (2005) it was also revealed that Cyp-D-defficient 
mice showed resistance to ischaemia/reperfusion injury as well as to ROS-induced 
necrotic cell death. From this observation emerged the hypothesis that through its 
PPIase activity Cyp-D may be involved in MPTP opening by facilitating a 
conformational change in a membrane protein (Juhaszova et al. 2008; Leung & 
Halestrap 2008). The identity of that membrane protein is, however, less certain. He 
and Lemasters (2002) debated whether specific membrane proteins are responsible 
for pore formation. According to their hypothesis the MPTP forms from misfolded 
integral membrane proteins as a result of oxidative damage or other stresses. The 
role of Cyp-D in this model is to block conductance at damage sites where misfolded 
proteins have aggregated forming the MPTP. Above a critical damage level the 
available Cyp-D is unable to block conductance and MPTP opening occurs. Although 
this model would elegantly explain why MPTP opening can occur in the absence of 
Cyp-D the fact that MPTP opening can be modulated by various ligands of the 
adenine nucleotide translocase (ANT) is inconsistent with such a hypothesis (Zoratti 
& Szabó 1995).  
The Adenine Nucleotide Translocase 
The involvement of ANT in MPTP formation was first put forward by Hunter and 
Haworth (1979). ANT is located in high amounts in the inner mitochondrial 
membrane. It is an antiporter that transports adenosine diphosphate (ADP) into the 
mitochondrial matrix where adenosine triphosphate (ATP) is generated through 
oxidative phosphorylation. The entry of one ADP is coupled to the exit of one ATP 
via the ANT (Berg et al. 2007). It is important to note that for the generation of ATP 
molecules adequate phosphate (Pi) supply is also necessary. Pi is imported into the 
matrix by another antiporter, the phosphate carrier (PiC) that couples the influx of Pi 
into the matrix to the efflux of hydroxyl ions into the inner membrane space (Lodish 
et al. 2008). Indeed, adenine nucleotide and Pi have been known as PT modulators 
for decades. The long-standing observation is that Pi is an inducer, whereas ATP 
and ADP (without bound Mg2+) are inhibitors of PT (Zoratti & Szabó 1995). Adenine 
nucleotide depletion during ischaemia, therefore, may lead to MPTP opening due to 
the loss of protection by ATP/ADP and a substantial rise of Pi concentration as a 
result of adenine nucleotide degradation (Halestrap et al. 2003). Since MPT-
associated swelling may result in the rupture of the outer mitochondrial membrane 
(OMM) and the subsequent release of pro-apoptotic proteins, such as cytochrome c 
and apoptosis inducing factor (AIF), from the inter-membrane space, research 
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interest turned to characterise MPT in the context of apoptosis (Crompton 1999). 
Nevertheless, the studies by Kim et al. (2003) revealed that adenine nucleotide 
depletion is a major factor that drives MPT-associated cellular changes towards 
necrotic cell death.    
Other modulators of MPTP opening used in mitochondrial research involve the 
respiratory toxins carboxyatractyloside (CAT) and bongkrekic acid (BKA). CAT 
induces pore opening while BKA has an inhibitory effect on MPT. They act by 
facilitating opposite changes in the conformational state of the ANT. CAT stabilises 
the “c” conformation where the nucleotide binding site faces the cytoplasmic side of 
the membrane. Conversely, BKA enhances the eversion of the binding site to the 
matrix side (“m” conformation). According to these observations the “c” conformation 
may be required for pore opening, whereas the “m” conformation is inhibitory (Zoratti 
& Szabó 1995). From the Ca2+ dependency of MPT Halestrap and Brenner (2003) 
suggested that there may be a Ca2+ trigger site exposed on the ANT associated with 
the “c” conformation. Although there is no conclusive evidence for the identity of this 
site, they proposed that glutamate and aspartate residues may bind calcium on the 
matrix side of the ANT. They further suggested that H+ ions might compete for these 
binding sites, which might result in the desensitisation of MPTP to Ca2+. Indeed, 
such a hypothesis appears to be supported by the observation that low pH inhibits 
MPTP opening (Zoratti & Szabó 1995).  
Changes in pH during ischaemia/reperfusion have important implications for cell 
survival. Data from several lines of research have confirmed that the acidic condition 
present during ischaemia is cytoprotective against necrotic cell death and cell killing 
only accelerates after reperfusion, when normal pH recovers (Halestrap 2006). 
However, according to Crompton (1999) the issue of MPTP-associated 
cytoprotection by low pH is more complex. He observed that MPTP opening still 
occurs at pH 6.5, a relatively low pH, which may contribute to a higher rate of H+ 
backflow through the open pore leading to the collapse of the membrane potential 
and the disruption of mitochondrial homeostasis. An alternative explanation may be, 
as proposed by Halestrap and Brenner (2003), that the higher membrane potential, a 
widely accepted inhibitor of MPTP opening, may facilitate greater binding of adenine 
nucleotides to the matrix side of the ANT, which, in turn, will exert its inhibitory effect 
through inducing the “m” conformation.  
More direct evidence that the ANT might function as a pore component came from 
the demonstration that ANT binds Cyp-D in a CsA-sensitive manner (Crompton et al. 
1998). It was also suggested that the role of Cyp-D in MPTP formation is to induce a 
conformational change in the ANT. The supporting evidence for this came from the 
observation that sanglifehrin A (SfA), a potent MPTP inhibitor, did not prevent Cyp-D 
from binding to the ANT (Clarke et al. 2002). It was also hypothesised that Cyp-D 
binding facilitates a conformational change in the ANT when triggered by Ca2+. CsA, 
therefore, inhibits this binding, whereas SfA inhibits the conformational change 
induced by Cyp-D (Clarke et al. 2002). This model is also consistent with the 
published three dimensional structure of the ANT in its CAT-bound form (Pebay-
Peyroula & Brandolin 2004). From this structure it appears that on the cytosolic 
surface ANT has a large channel that extends deep into the membrane and is 
blocked by a narrow gate at the matrix side. The conformational change would, 
therefore, be necessary to wedge this gate open (Leung & Halestrap 2008). 
Nevertheless, the fact that at very high Ca2+ concentration MPTP opening can be 
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observed without the involvement of Cyp-D renders the evidence for a Cyp-D-
induced conformational change in the ANT largely circumstantial (Baines et al. 
2005).     
Despite the several lines of evidence implicating the ANT in the formation of the 
MPTP, experiments performed on ANT1/ANT2 knock-out mice have revealed that 
the involvement of the ANT in MPT is not an absolute requirement. Kokoszka et al. 
(2004) observed that, albeit at high Ca2+ concentrations, MPTP opening still 
occurred in mouse mitochondria lacking the two isoforms of ANT. Nevertheless, the 
fact that the mice in which the ANT1/ANT2 isoforms had been knocked out displayed 
no obvious disruption of urea synthesis and gluconeogenesis, metabolic processes 
that rely on the export of ATP from the mitochondria, points to the possible 
involvement of ANT isoforms other than ANT1/ANT2 (Leung & Halestrap 2008). 
Proteomic studies by Cruz et al. (2003) on mouse liver mitochondrial inner 
membrane, indeed, confirmed the presence of a new ANT isoform, the ANT4. 
Nevertheless, the fact that the MPTP opening observed by Kokoszka et al. (2004) 
was insensitive to ligands of the ANT suggests that ANT was not involved in pore 
opening. An explanation suggested by Palmieri (2004) may be that ANT is a member 
of a large family of mitochondrial carriers with structural similarities and it is possible 
that other members of this family may be involved in MPTP opening as well.  
Another line of evidence questioning the primary role of ANT in MPTP formation has 
been put forward by Leung and Halestrap (2008). In their study they investigated the 
interaction between CAT and a thiol reagent, phenylarsine oxide (PAO), with regard 
to MPTP opening. According to their results both CAT and PAO are able to bind ANT 
and stimulate MPTP opening. It was also revealed that ANT from rat mitochondria 
pre-treated with CAT is not able to bind to a PAO-affinity matrix. However, when 
CAT-treated mitochondria were exposed to PAO, as illustrated in Fig.1, an even 
greater effect on MPTP opening could be observed (Leung & Halestrap 2008). 
Therefore, it can be concluded that apart from ANT, which more likely has a 
regulatory role only, other mitochondrial membrane proteins may be involved in 
MPTP formation as well. 
 
Fig.1 PAO can activate MPTP opening in CAT treated mitochondria. Polyethylene glycol-
induced shrinkage was measured as a function of ADP concentration. The rate of shrinkage 
corresponds to the degree of MPTP opening, that is, the loss of sensitivity to inhibition by 
ADP. Adapted from Leung and Halestrap (2008). 
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Other possible components of the MPTP 
Until recently, first proposed by Zoratti and Szabó (1994) the voltage dependent 
anion channel (VDAC) has been known to play a role in pore formation. The VDAC, 
also known as porin, is located in the outer mitochondrial membrane and forms a 
channel that is permeable to water soluble metabolites up to the size of 5 kDa (Ha et 
al.1993). The evidence for its involvement in MPTP opening was originally based on 
the observation that VDAC co-purifies with the ANT and the benzodiazepine receptor 
(McEnery et al. 1992). The association of VDAC with the ANT was thought to occur 
at contact sites where the outer and the inner mitochondrial membranes are very 
close to each other (Crompton 2000). Indeed, these sites have been implicated in 
channelling proteins, metabolites, and ions into the mitochondrial matrix (Ardail et al. 
1990). Crompton (2000) hypothesised that MPTP forms at these contact sites 
through the binding of the VDAC to the ANT. This hypothesis was also supported by 
Cesura et al. (2003) who used ubiquinone analogues, potent inhibitors of MPT, in 
search of the pore forming components. Through radioactive labelling they found 
that the 32 kDa protein co-purified with the labelled ubiquinone analogue 
corresponded to the VDAC1 isoform. Recent studies by two research groups, 
however, have questioned if any of the three known isoforms of VDAC are involved 
in MPTP opening (Krauskopf et al. 2006; Baines et al. 2007). They generated mice 
deficient for the isoforms VDAC1 and VDAC3 (VDAC2 deficiency was non-viable) 
and assessed their mitochondria with regard to MPT. It was revealed that MPT could 
be induced in the mitochondria from mice deficient for any of the two or both 
isoforms of VDAC. Although the results from these genetic studies cast some doubt 
on the findings of Cesure et al. (2003), the fact that ubiquinone analogues inhibit 
MPT prompted more studies in this line of research.  
Leung and Halestrap (2008) suggested that the ubiquinone analogues may exert 
their inhibitory effect on MPTP opening by binding to the ANT and the PiC. They 
demonstrated that, when run on SDS-PAGE, both the ANT and the PiC were in the 
30-34 kDa region, therefore, the two intermembrane proteins may be potential 
candidates for the protein identified by Cesura et al. (2003). Indeed, Leung et al. 
(2008) stated that according to their results ubiquinone analogues bind to the ANT 
and the PiC. Since PAO facilitates MPTP opening it was logical to assume that these 
proteins also bind to a PAO affinity matrix. As already mentioned above, the ANT 
binds to PAO unless the mitochondria are pre-treated with CAT. As expected the 
binding of PiC to PAO was also demonstrated and it was found that CAT treatment 
did not influence this binding (Leung & Halestrap 2008). Thus, PiC may fulfil the role 
of the inner membrane pore component of the MPTP. Although the presence of two 
other inner membrane proteins could also be detected in the region of 30-35 kDa, 
the idea that they are involved in MPT as a pore component was not supported. One 
of the proteins, adenylate kinase 2 (AK2) is a soluble inter-membrane space protein 
that cannot function as a membrane component. In addition it was demonstrated that 
inhibition of its activity by P1,P5-di(adenoside-5’) pentaphosphate did not affect 
MPTP opening. The other protein was NIPSNAP-2, a protein of unknown function 
(Leung & Halestrap 2008). As opposed to these two proteins, several lines of 
evidence have been reported in support of the involvement of the PiC in MPT. 
According to Leung and Halestrap (2008), apart from pore opening ubuquinone 
analogues can also inhibit phosphate transport into the mitochondrial matrix. 
Research by Krämer (1998) demonstrated that if crosslinked between two cysteine 
residues, the PiC from S. cerevisiae mitochondria expressed in E. coli can function 
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as a non-specific anion channel, a characteristic of MPTP. Furthermore, the data 
from studies by Leung et al. (2008) indicate that the PiC binds Cyp-D in a CsA-
sensitive manner. The same group also revealed that the PiC can be co-
immunoprecipitated with the ANT from CAT-treated mitochondria suggesting that the 
PiC, ANT, and Cyp-D may form a complex during the MPT. In view of their recent 
findings Leung and Halestrap (2008) proposed a model in which the PiC is the 
MPTP forming component. PiC can be induced by an elevated Ca2+ concentration to 
undergo a conformational change that is needed for pore formation. Although this 
conformational change is also facilitated by Cyp-D and the ANT in the “c” 
conformation, they are not required for MPTP opening at a much higher Ca2+ load.  
Conclusion 
In spite of several decades of research the molecular nature of the MPTP 
components remains debated. Studies in the field have been carried out mainly in 
the context of ischaemia/reperfusion injury because the molecular triggers that 
induce MPT are also present in the condition. Through biochemical and genetic 
approaches the involvement of several mitochondrial proteins of known function has 
been suggested. According to a recent finding the PiC has been identified as the 
major pore forming component. Its involvement as a potential candidate has been 
supported by data from several lines of research; nevertheless, from gene knockout 
experiments it still awaits confirmation (Leung & Halestrap 2008). Similar knockout 
studies have ruled out the ANT as an MPTP component, however, it may have a 
regulatory role that requires further characterisation. Biochemical and genetic studies 
have confirmed that CyP-D and VDAC are not involved in pore formation; 
nonetheless, CyP-D may have an effect on MPTP opening through its PPIase 
activity. Although MPTP opening may result in the rupture of the OMM and the 
subsequent release of pro-apoptotic proteins such as cytochrome c and AIF, there is 
accumulating evidence that MPTP opening is mainly responsible for causing necrotic 
cell death. Nevertheless, further studies aimed at characterising both apoptotic and 
necrotic cell death may contribute to this field of mitochondrial research.   
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